國立虎尾科技大學 |

Drug resistance in leishmania parasites = consequences, molecular mechanisms and possible treatments /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Drug resistance in leishmania parasites/ edited by Alicia Ponte-Sucre, Maritza Padron-Nieves.
Reminder of title:	consequences, molecular mechanisms and possible treatments /
other author:	Ponte-Sucre, Alicia.
Published:	Cham :Springer International Publishing : : 2018.,
Description:	xvii, 376 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Leishmaniasis. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-74186-4
ISBN:	9783319741864

Drug resistance in leishmania parasites = consequences, molecular mechanisms and possible treatments /
Drug resistance in leishmania parasitesconsequences, molecular mechanisms and possible treatments /[electronic resource] :edited by Alicia Ponte-Sucre, Maritza Padron-Nieves. - 2nd ed. - Cham :Springer International Publishing :2018. - xvii, 376 p. :ill., digital ;24 cm.

Prologue -- Introduction -- Part I Determinant features in Leishmaniasis -- Molecular evolution and phylogeny of Leishmania -- The role of reservoirs: canine Leishmaniasis -- Epidemiology of Leishmaniasis in the time of drug resistance -- The role of the immune system in resistance to infection -- Part II Challenges in the diagnosis, treatment and control of Leishmaniasis in the times of drug resistance -- Co-infection with HIV -- Visceral Leishmaniasis -- Tegumentary Leishmaniasis -- Antimony accounted sequel post Kala-Azar dermal Leishmaniasis -- Part III Molecular featrues of drug resistant Leishmania -- Genetic Expression and drug resistance, the role of proteomics -- The role of AMC transporters in drug-resistant Leishmania -- Functional analysis of Leishmania membrane (non AMC) transporters involved in drug resistance -- Part IV Pharmacology and chemotherapy of Leishmaniasis -- Classical vs. novel treatment regimens -- Bioinformatics in Leishmania drug design -- Leishmanis mitochondria, a druggable organelle -- P-glycoprotein-like transporters in Leishmania: a search for reversal agents -- Part V Strategies to circumvent drug resistance in Leishmania -- The relevance of susceptibility tests, breakpoints and markers -- The concept of fitness in Leishmania.

Drug resistance is a fundamental factor in treatment failure in diseases like leishmaniasis, although additional factors also play a role in this phenomenon. This volume is the second edition of a well-received book that provides a comprehensive update on the pathology of the disease, as well as on the concept of parasitic drug resistance, its molecular basis, consequences and possible treatments. A valuable resource for scientists both from academia and industry involved in biomedical research and drug design, the book provides the knowledge needed to understand leishmaniasis and to contibute to combatting this disease worldwide.

ISBN: 9783319741864

Standard No.: 10.1007/978-3-319-74186-4doiSubjects--Topical Terms:

1021816
Leishmaniasis.

LC Class. No.: RC153 / .D784 2018

Dewey Class. No.: 616.9364

Drug resistance in leishmania parasites = consequences, molecular mechanisms and possible treatments /
LDR:02972nam a2200325 a 4500 001 928221
003 DE-He213
005 20190225094126.0
006 m d
007 cr nn 008maaau
008 190626s2018 gw s 0 eng d
020 $a 9783319741864 $q (electronic bk.)
020 $a 9783319741857 $q (paper)
024 7 $a 10.1007/978-3-319-74186-4 $2 doi
035 $a 978-3-319-74186-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC153 $b .D784 2018
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
082 0 4 $a 616.9364 $2 23
090 $a RC153 $b .D794 2018
245 0 0 $a Drug resistance in leishmania parasites $h [electronic resource] : $b consequences, molecular mechanisms and possible treatments / $c edited by Alicia Ponte-Sucre, Maritza Padron-Nieves.
250 $a 2nd ed.
260 $a Cham : $c 2018. $b Springer International Publishing : $b Imprint: Springer,
300 $a xvii, 376 p. : $b ill., digital ; $c 24 cm.
505 0 $a Prologue -- Introduction -- Part I Determinant features in Leishmaniasis -- Molecular evolution and phylogeny of Leishmania -- The role of reservoirs: canine Leishmaniasis -- Epidemiology of Leishmaniasis in the time of drug resistance -- The role of the immune system in resistance to infection -- Part II Challenges in the diagnosis, treatment and control of Leishmaniasis in the times of drug resistance -- Co-infection with HIV -- Visceral Leishmaniasis -- Tegumentary Leishmaniasis -- Antimony accounted sequel post Kala-Azar dermal Leishmaniasis -- Part III Molecular featrues of drug resistant Leishmania -- Genetic Expression and drug resistance, the role of proteomics -- The role of AMC transporters in drug-resistant Leishmania -- Functional analysis of Leishmania membrane (non AMC) transporters involved in drug resistance -- Part IV Pharmacology and chemotherapy of Leishmaniasis -- Classical vs. novel treatment regimens -- Bioinformatics in Leishmania drug design -- Leishmanis mitochondria, a druggable organelle -- P-glycoprotein-like transporters in Leishmania: a search for reversal agents -- Part V Strategies to circumvent drug resistance in Leishmania -- The relevance of susceptibility tests, breakpoints and markers -- The concept of fitness in Leishmania.
520 $a Drug resistance is a fundamental factor in treatment failure in diseases like leishmaniasis, although additional factors also play a role in this phenomenon. This volume is the second edition of a well-received book that provides a comprehensive update on the pathology of the disease, as well as on the concept of parasitic drug resistance, its molecular basis, consequences and possible treatments. A valuable resource for scientists both from academia and industry involved in biomedical research and drug design, the book provides the knowledge needed to understand leishmaniasis and to contibute to combatting this disease worldwide.
650 0 $a Leishmaniasis. $3 1021816
650 0 $a Drug resistance in microorganisms. $3 644229
650 0 $a Medical parasitology. $3 862634
650 1 4 $a Biomedicine. $3 593880
650 2 4 $a Drug Resistance. $3 782695
650 2 4 $a Infectious Diseases. $3 668393
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 2 4 $a Vaccine. $3 782685
650 2 4 $a Parasitology. $3 669054
650 2 4 $a Microbiology. $3 591510
700 1 $a Ponte-Sucre, Alicia. $3 1072063
700 1 $a Padron-Nieves, Maritza. $3 1072065
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-74186-4
950 $a Biomedical and Life Sciences (Springer-11642)